Efficacy & Safety of Abaloparatide-Solid Microstructured Transdermal System in Postmenopausal Women With Osteoporosis

NCT04064411 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

511

Enrollment

INDUSTRY

Sponsor class

Conditions

Postmenopausal Osteoporosis

Interventions

COMBINATION_PRODUCT: abaloparatide
COMBINATION_PRODUCT: abaloparatide solid microstructured transdermal system

Sponsor

Radius Health, Inc.